Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

The Journal of Allergy and Clinical Immunology
Stephen R DurhamSabina Rak

Abstract

Specific immunotherapy is the only treatment modality that has the potential to alter the natural course of allergic diseases. Sublingual immunotherapy has been developed to facilitate access to this form of treatment and to minimize serious adverse events. To investigate the efficacy and safety of sublingual grass allergen tablets in seasonal allergic rhinoconjunctivitis. A multinational, multicenter, randomized, placebo-controlled trial conducted during 2002 and 2003. Fifty-five centers in 8 countries included 855 participants age 18 to 65 years who gave a history of grass pollen-induced allergic rhinoconjunctivitis and had a positive skin prick test and elevated serum allergen-specific IgE to Phleum pratense. Participants were randomized to 2500, 25,000, or 75,000 SQ-T grass allergen tablets (GRAZAX; ALK-Abelló, Hørsholm, Denmark) or placebo for sublingual administration once daily. Mean duration of treatment was 18 weeks. Average rhinoconjunctivitis scores during the season showed moderate reductions of symptoms (16%) and medication use (28%) for the grass allergen tablet 75,000 SQ-T (P = .0710; P = .0470) compared with placebo. Significantly better rhinoconjunctivitis quality of life scores (P = .006) and an increased numb...Continue Reading

Citations

Nov 20, 2009·Inflammatory Bowel Diseases·Pritash PatelJeremy Sanderson
May 19, 2011·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·H LeeM Worm
Feb 28, 2009·Wiener medizinische Wochenschrift·Isabella Pali-SchöllJean Bousquet
Oct 13, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Sabina RakStephen R Durham
Apr 18, 2008·Current Allergy and Asthma Reports·Linda Cox
Oct 23, 2008·Current Allergy and Asthma Reports·Désirée Larenas-Linnemann
Aug 11, 2006·Current Allergy and Asthma Reports·Giovanni PassalacquaGiorgio Walter Canonica
Apr 28, 2009·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Ivor A EmanuelOren Traub
Apr 28, 2009·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·John H Krouse
Feb 12, 2009·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Enrico CompalatiGiorgio Walter Canonica
Mar 7, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Désirée Larenas-LinnemannUNKNOWN Immunotherapy and Allergy Diagnostics Committee of the American Academy of Allergy, Asthma and Immunology
Apr 23, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Oliver Pfaar, Ludger Klimek
Jun 4, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Robert E EschRichard F Lockey
Sep 26, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Noel Rodríguez-PérezMartin Penagos
Apr 27, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jens KildsgaardKaare Lund
May 24, 2008·The New England Journal of Medicine·Anthony J Frew
Nov 26, 2010·Current Opinion in Otolaryngology & Head and Neck Surgery·Giovanni PassalacquaGiorgio W Canonica
Mar 3, 2010·Annual Review of Immunology·Rudolf ValentaSusanne Vrtala
Sep 22, 2006·Annual Review of Medicine·E William St ClairJeffrey Bluestone
Jul 28, 2009·Annual Review of Medicine·David H Broide
Apr 14, 2012·Journal of Allergy·Mary S MorrisDavid L Morris
Aug 22, 2009·American Journal of Respiratory and Critical Care Medicine·Robyn E O'HehirAlessandra Sandrini
Nov 11, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Cristoforo IncorvaiaFranco Frati
Jun 11, 2011·Journal of Asthma and Allergy·Cristoforo IncorvaiaFranco Frati
May 11, 2011·Immunotherapy·Cristoforo Incorvaia, Franco Frati
Jun 15, 2011·Immunotherapy·Nerin Nadir Bahceciler, Nazan Cobanoglu
Mar 7, 2012·American Journal of Rhinology & Allergy·Sarah K Wise, Rodney J Schlosser
Nov 5, 2011·Asia Pacific Allergy·Doo Hee Han, Chae-Seo Rhee
Feb 19, 2013·Immunotherapy·Nerin Nadir BahcecilerNazan Cobanoglu
Mar 1, 2013·Immunotherapy·Giovanni PassalacquaGiorgio Walter Canonica
Mar 13, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Melina MakatsoriMoises A Calderon
Mar 13, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Linda S CoxRichard Lockey
Mar 13, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Harold S Nelson
Apr 1, 2014·The World Allergy Organization Journal·Giorgio Walter CanonicaOsman Yusuf
Aug 7, 2014·Clinical and Translational Allergy·Ludger KlimekOliver Pfaar
Oct 14, 2014·The World Allergy Organization Journal·Giovanni Passalacqua
Sep 10, 2014·Current Allergy and Asthma Reports·David C Jay, Kari C Nadeau
Feb 17, 2015·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Jacques HébertHendrik Nolte
Jun 2, 2009·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Guy Scadding, Stephen Durham
Sep 21, 2012·Expert Review of Clinical Immunology·Dai ParkMichael S Blaiss
Sep 12, 2015·Expert Review of Clinical Immunology·Giorgio CiprandiAmelia Licari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.